$5.840
0.000 (0.00%)At close
ALTM News
ALTM Events
Entegris to replace Arcadium Lithium in the S&P 400 at open on 3/6
Entegris (ENTG) will replace Arcadium Lithium (ALTM) in the S&P MidCap 400 effective prior to the opening of trading on Thursday, March 6. Rio Tinto (RIO) is acquiring Arcadium Lithium in a deal expected to be completed soon, pending final closing conditions.
Entegris to replace Arcadium Lithium in the S&P 400 at open on 3/6
Entegris (ENTG) will replace Arcadium Lithium (ALTM) in the S&P MidCap 400 effective prior to the opening of trading on Thursday, March 6. Rio Tinto (RIO) is acquiring Arcadium Lithium in a deal expected to be completed soon, pending final closing conditions.
Arcadium Lithium withdraws prior financial guidance
As a result of its pending acquisition by Rio Tinto (RIO), announced on October 9, 2024, and as is customary during such transactions, Arcadium Lithium (ALTM) will not hold an earnings conference call in connection with its fourth quarter and full year financial results. For the same reason, the company withdrew its prior operating and financial guidance and will not be introducing guidance for 2025.
Arcadium Lithium reports Q4 adjusted EPS (1c), consensus 2c
Reports Q4 revenue $289M, consensus $250.96M.
Arcadium Lithium gets all regulatory approvals for acquisition by Rio Tinto
Arcadium Lithium (ALTM) has now received all required pre-closing regulatory approvals in connection with the proposed acquisition of Arcadium Lithium by Rio Tinto (RIO). This includes merger control clearance being satisfied or waived in Australia, Canada, China, Japan, South Korea, the United Kingdom and the United States, as well as investment screening approval being satisfied in Australia, Canada, Italy, the United Kingdom and the United States. In connection with completion of the transaction, Arcadium's shares and Chess Depositary Receipts will be delisted from the New York Stock Exchange and the Australian Securities Exchange respectively.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.